Source: Sustainable Brands
“Steve Schueth has this right. Whether we are representing funds or the underlying innovators, the key shift in measurement is a 800 pound gorilla in the room: What are we doing to move the pendulum on the UN SDGs? Are we allocating enough dollars? Is the movement on track, or not? Increasingly, the conversation has shifted toward meeting the SDGs. The exciting development now is that funds and companies appear to be moving in a direction where a single deployment can have long-term measurable effect on multiple SDG objectives: e.g. what if you can bring dispatchable power to an off-grid community, but also provide potable water, heat and connectivity? What if you can deliver these commodities in a clean, sustainable, and affordable format? What if these achievements can bring remote medicine via Telehealth? Now you are moving the needle in a meaningful way. This is the type of analysis that will drive real change and create the powerful measurement tool that reaches beyond SRI 1.0 and 2.0. In the healthcare verticals, such as Disease Eradication, we are seeing the same type of thinking: are there ways to apply a particular solution across a broader spectrum. The leaders who I fondly refer to as the “Pioneers” are increasingly finding ways to create multiple impact solutions.”
-- John Shire is Partner in the Corporate Department of the Washington, D.C. office of Seyfarth Shaw and is the head of the Impact Investment practice.